Compound Pre-filled Syringes

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
W91YTZ-19-R-0037
Agency
Medical Command Department of the Army, Department of Defense
Responses due
Set-aside
Total Small Business

Opportunity facts

NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
Not on record
Place of performance
Eisenhower Army Medical Center 300 East Hospital Road Fort Gordon, Georgia 30905, United States

Notice details come from SAM.gov. Updated .

Notice text

2 versions

Update #2 · Latest ·

The purpose of this modification is to extend the solicitation closing date FROM: June 7, 2019 12:00 PM EST TO: June 12, 2019p 12:00 PM EST and provide responses to the following questions:
1. Is there a specific requirement for glass or plastic syringes? Plastic
2. Is (PF) defined as "Preservative Free"? Yes, preservative free
3. What is the requested concertration of Esmolol? Concertration is provided in updated Attachment 1 of the solicitation.
4. What is the requested concentration of Ketamine? Concertration is provided in updated Attachment 1 of the solicitation.
5. What is the requested diluent for Lidocaine 2%? Diluent provided in updated Attachment 1 of the solicitation.
6. What is the requested 15ml diluent for Rocuronium Bromide? Diluent provided in updated Attachment 1 of the solicitation.
7. What are the case quantities of each item? 25.

Update #1 ·

Compound pre-filled Syringes.

Attachments

Files attached to this notice, newest first
File Type Posted
Combined_Synposis_and_Solicitation_Amendment_W91YTZ-19-R-0037.pdf PDF
Combined_Synposis_and_Solicitation_Compound_Syringes.pdf PDF

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
Compound Pre-filled Syringes Award Award Notice
Compound Pre-filled Syringes This notice · Latest solicitation Solicitation

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity